This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057108323127v1 13/9/855    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hostetler, H. A. Articles by Kier, A. B. Search for Related Content PubMed PubMed Citation Articles by Hostetler, H. A. Articles by Kier, A. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE Social Bookmarking                         What's this?

A Novel High-Throughput Screening Assay for Putative Antidiabetic Agents through PPAR Interactions

^* To whom correspondence should be addressed. E-mail: akier{at}cvm.tamu.edu.

	Abstract

As natural peroxisome proliferator-activated receptor- (PPAR) ligands, high levels of fatty acids and glucose could lead to hyperactivation of PPAR, like that seen in diabetes. Important diabetes research goals are to uncover new metabolic or signaling pathways involved in hyperglycemic cellular injury and to develop therapeutics for preventing or reversing this injury. Consequently, 1040 putative antidiabetic agents were screened for their ability to 1) affect PPAR lipid binding, 2) directly bind PPAR, and 3) alter PPAR transactivation in the presence of high glucose. A high-throughput fluorescent binding assay was developed to examine each compound’s ability to restore fatty acyl-CoA binding to PPAR in the presence of high glucose concentrations. Approximately 1% of the compounds restored acyl-CoA binding by 60% or more. These compounds directly interacted with PPAR with high affinity (nM K_ds), validating the primary screen. Furthermore, these compounds altered PPAR transactivation, and 1 strongly reversed the hyperactivation of PPAR found in the presence of clofibrate and high glucose levels. (Journal of Biomolecular Screening XXXX:xx-xx)

First published on September 23, 2008, doi:10.1177/1087057108323127

Journal of Biomolecular Screening 2008;13:855.

A more recent version of this article appeared on October 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?